Literature DB >> 6996813

Growth-inhibitory activity of the D-mannan of Saccharomyces cerevisiae X2180-1A-5 mutant strain against mouse-implanted sarcoma 180 and Ehrlich-carcinoma solid tumor.

T Matsumoto, M Takanohashi, Y Okubo, M Suzuki, S Suzuki.   

Abstract

The D-mannan of Saccharomyces cerevisiae X2180-1A-5 mutant strain, which possesses a main chain composed of alpha-(1 yields 6) linked D-mannopyranosyl residues and a small proportion of branches composed of alpha-(1 yields 2)- and alpha-(1 yields 3)-linked D-mannopyranosyl residues, showed strong growth-inhibitory activity against mouse-implanted Sarcoma 180 and Ehrlich-carcinoma solid tumor. The observation that the level of this activity was nearly identical with that of the D-mannan of a wild-type strain of bakers' yeast, which possesses a high proportion of branches composed of alpha-(1 yields 2)-and alpha-(1 yields 3)-linked D-mannopyranosyl residues, suggests that the branches are not essential for antitumor activity. The partial acid-degradation products of both D-mannans, the molecular weight of which was one-third of that of each parent D-mannan, had only one half of the antitumor activity of the parent D-mannans. This suggests that molecular size is the most important factor for the differences in acitvity of the polysaccharides of wild and mutant strains.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6996813     DOI: 10.1016/s0008-6215(00)84548-6

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  2 in total

1.  Antitumor effect of heat-killed Aspergillus fumigatus mycelium in a mouse model.

Authors:  J B deKernion; L Lovrekovich
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

2.  Mannan oligosaccharide requires functional ETC and TLR for biological radiation protection to normal cells.

Authors:  Sweta Sanguri; Damodar Gupta
Journal:  BMC Cell Biol       Date:  2018-06-27       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.